{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:12:55Z","timestamp":1792548775931,"version":"4.5.0"},"reference-count":83,"publisher":"The Company of Biologists","issue":"8","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010311","name":"Core","doi-asserted-by":"crossref","award":["MD014726"],"award-info":[{"award-number":["MD014726"]}],"id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U.S. Department of Defense","award":["W81XWH-14-1-0333"],"award-info":[{"award-number":["W81XWH-14-1-0333"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["MD007092"],"award-info":[{"award-number":["MD007092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vertex Pharmaceutical"},{"DOI":"10.13039\/100000863","name":"Ellison Medical Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000863","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>People of recent sub-Saharan African ancestry develop kidney failure much more frequently than other groups. A large fraction of this disparity is due to two coding sequence variants in the APOL1 gene. Inheriting two copies of these APOL1 risk variants, known as G1 and G2, causes high rates of focal segmental glomerulosclerosis (FSGS), HIV-associated nephropathy and hypertension-associated end-stage kidney disease. Disease risk follows a recessive mode of inheritance, which is puzzling given the considerable data that G1 and G2 are toxic gain-of-function variants. We developed coisogenic bacterial artificial chromosome (BAC) transgenic mice harboring either the wild-type (G0), G1 or G2 forms of human APOL1. Expression of interferon gamma (IFN-\u03b3) via plasmid tail vein injection results in upregulation of APOL1 protein levels together with robust induction of heavy proteinuria and glomerulosclerosis in G1\/G1 and G2\/G2 but not G0\/G0 mice. The disease phenotype was greater in G2\/G2 mice. Neither heterozygous (G1\/G0 or G2\/G0) risk variant mice nor hemizygous (G1\/\u2212, G2\/\u2212) mice had significant kidney injury in response to IFN-\u03b3, although the heterozygous mice had a greater proteinuric response than the hemizygous mice, suggesting that the lack of significant disease in humans heterozygous for G1 or G2 is not due to G0 rescue of G1 or G2 toxicity. Studies using additional mice (multicopy G2 and a non-isogenic G0 mouse) supported the notion that disease is largely a function of the level of risk variant APOL1 expression. Together, these findings shed light on the recessive nature of APOL1-nephropathy and present an important model for future studies.<\/jats:p>","DOI":"10.1242\/dmm.048952","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:39:43Z","timestamp":1628159983000},"source":"Crossref","is-referenced-by-count":68,"title":["Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease"],"prefix":"10.1242","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0607-8469","authenticated-orcid":false,"given":"Gizelle M.","family":"McCarthy","sequence":"first","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Blasio","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia G.","family":"Donovan","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena B.","family":"Schaller","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5544-9740","authenticated-orcid":false,"given":"Althea","family":"Bock-Hughes","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-1221","authenticated-orcid":false,"given":"Jose M.","family":"Magraner","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Suh","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum F.","family":"Tattersfield","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-5060","authenticated-orcid":false,"given":"Isaac E.","family":"Stillman","sequence":"additional","affiliation":[{"name":"Dept. of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-7507","authenticated-orcid":false,"given":"Shrijal S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-5728","authenticated-orcid":false,"given":"Zsuzsanna K.","family":"Zsengeller","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-0257","authenticated-orcid":false,"given":"Balajikarthick","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-9725","authenticated-orcid":false,"given":"Martin R.","family":"Pollak","sequence":"additional","affiliation":[{"name":"Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"2022012608060038000_DMM048952C1","doi-asserted-by":"publisher","first-page":"e126124","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-\u03b3-induced proteinuria in APOL1-transgenic mice","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"},{"key":"2022012608060038000_DMM048952C2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0092-8674(88)90050-5","article-title":"Molecular cloning and expression of the human interferon-\u03b3 receptor","volume":"55","author":"Aguet","year":"1988","journal-title":"Cell"},{"key":"2022012608060038000_DMM048952C3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat. Med"},{"key":"2022012608060038000_DMM048952C4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"2022012608060038000_DMM048952C5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1681\/ASN.2013070700","article-title":"Plasma apolipoprotein L1 levels do not correlate with CKD","volume":"25","author":"Bruggeman","year":"2014","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C6","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C7","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00426.2018","article-title":"APOL1 polymorphisms and kidney disease: Loss-of-function or gain-of-function?","volume":"316","author":"Bruggeman","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"2022012608060038000_DMM048952C8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000481634","article-title":"Protecting podocytes: a key target for therapy of focal segmental glomerulosclerosis","volume":"47","author":"Campbell","year":"2018","journal-title":"Am. J. Nephrol"},{"key":"2022012608060038000_DMM048952C9","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2215\/CJN.01180117","article-title":"APOL1 risk variants, incident proteinuria, and subsequent eGFR decline in blacks with hypertension-attributed CKD","volume":"12","author":"Chen","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C10","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1073\/pnas.1820414116","article-title":"Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity","volume":"116","author":"Chun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022012608060038000_DMM048952C11","doi-asserted-by":"publisher","first-page":"e25461","DOI":"10.7554\/eLife.25461","article-title":"APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis","volume":"6","author":"Cooper","year":"2017","journal-title":"Elife"},{"key":"2022012608060038000_DMM048952C12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.ki.5002655","article-title":"Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts)","volume":"73","author":"D'Agati","year":"2008","journal-title":"Kidney Int."},{"key":"2022012608060038000_DMM048952C13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1681\/ASN.2020010079","article-title":"Kidney disease-associated APOL1 variants have dose-dependent, dominant toxic gain-of-function","volume":"31","author":"Datta","year":"2020","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.semnephrol.2015.04.008","article-title":"APOL1 kidney disease risk variants: an evolving landscape","volume":"35","author":"Dummer","year":"2015","journal-title":"Semin. Nephrol."},{"key":"2022012608060038000_DMM048952C15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","author":"Freedman","year":"2015","journal-title":"Am. J. Transplant"},{"key":"2022012608060038000_DMM048952C18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased african American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"2022012608060038000_DMM048952C19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 nephropathy: from genetics to clinical applications","volume":"16","author":"Friedman","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C20","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"2022012608060038000_DMM048952C22","doi-asserted-by":"publisher","first-page":"e51546","DOI":"10.1371\/journal.pone.0051546","article-title":"APOL1 null alleles from a rural village in india do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS ONE"},{"key":"2022012608060038000_DMM048952C23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2018.18.e33","article-title":"Direct antiviral mechanisms of interferon-gamma","volume":"18","author":"Kang","year":"2018","journal-title":"Immune Netw"},{"key":"2022012608060038000_DMM048952C24","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C26","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS Clinical Trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C27","first-page":"51481","article-title":"Transient expression of proteins by hydrodynamic gene delivery in mice","author":"Kovacsics","year":"2014","journal-title":"J. Vis. Exp"},{"key":"2022012608060038000_DMM048952C28","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.ajpath.2018.07.025","article-title":"Role of apolipoprotein L1 in human parietal epithelial cell transition","volume":"188","author":"Kumar","year":"2018","journal-title":"Am. J. Pathol."},{"key":"2022012608060038000_DMM048952C29","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1038\/s41598-019-39376-y","article-title":"Disruption of APOL1-miR193a axis induces disorganization of podocyte actin cytoskeleton","volume":"9","author":"Kumar","year":"2019","journal-title":"Sci. Rep."},{"key":"2022012608060038000_DMM048952C30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.kint.2019.07.010","article-title":"Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background","volume":"96","author":"Lannon","year":"2019","journal-title":"Kidney Int."},{"key":"2022012608060038000_DMM048952C31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ki.2015.140","article-title":"Alternatively spliced isoforms of WT1 control podocyte-specific gene expression","volume":"88","author":"Lefebvre","year":"2015","journal-title":"Kidney Int."},{"key":"2022012608060038000_DMM048952C33","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1681\/ASN.2014040405","article-title":"Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys","volume":"26","author":"Li","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4132\/jptm.2016.09.21","article-title":"Pathogenesis of focal segmental glomerulosclerosis","volume":"50","author":"Lim","year":"2016","journal-title":"J. Pathol. Transl. Med"},{"key":"2022012608060038000_DMM048952C35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv. Chronic Kidney Dis"},{"key":"2022012608060038000_DMM048952C36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ki.2015.109","article-title":"APOL1 toxin, innate immunity, and kidney injury","volume":"88","author":"Limou","year":"2015","journal-title":"Kidney Int."},{"key":"2022012608060038000_DMM048952C37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.34067\/KID.0000422019","article-title":"Profiling APOL1 nephropathy risk variants in genome-edited kidney organoids with single-cell transcriptomics","volume":"1","author":"Liu","year":"2020","journal-title":"Kidney360"},{"key":"2022012608060038000_DMM048952C38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2353\/ajpath.2006.050398","article-title":"Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury","volume":"168","author":"Macconi","year":"2006","journal-title":"Am. J. Pathol"},{"key":"2022012608060038000_DMM048952C40","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.xkme.2020.05.004","article-title":"COVID-19\u2013Related glomerulopathy: a report of 2 cases of collapsing focal segmental glomerulosclerosis","volume":"2","author":"Magoon","year":"2020","journal-title":"Kidney Med"},{"key":"2022012608060038000_DMM048952C42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-\u03b1,-\u03b2,or-\u03b3 is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fendo.2018.00302","article-title":"Nephrin signaling in the podocyte: An updated view of signal regulation at the slit diaphragm and beyond","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2022012608060038000_DMM048952C44","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1681\/ASN.2005111200","article-title":"Racial differences in the prevalence of chronic kidney disease among participants in the reasons for geographic and racial differences in stroke (REGARDS) cohort study","volume":"17","author":"McClellan","year":"2006","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C45","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"2022012608060038000_DMM048952C46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jgm.1317","article-title":"Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression","volume":"11","author":"Mitsui","year":"2009","journal-title":"J. Gene Med"},{"key":"2022012608060038000_DMM048952C47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.molbiopara.2005.08.018","article-title":"Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes","volume":"144","author":"Molina-Portela","year":"2005","journal-title":"Mol. Biochem. Parasitol"},{"key":"2022012608060038000_DMM048952C48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1006\/geno.2002.6729","article-title":"The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue","volume":"79","author":"Monajemi","year":"2002","journal-title":"Genomics"},{"key":"2022012608060038000_DMM048952C49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann. Intern. Med"},{"key":"2022012608060038000_DMM048952C50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int."},{"key":"2022012608060038000_DMM048952C51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-018-0188-2","article-title":"APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R","volume":"1","author":"Okamoto","year":"2018","journal-title":"Commun. Biol."},{"key":"2022012608060038000_DMM048952C52","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022012608060038000_DMM048952C53","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1681\/ASN.2016121322","article-title":"ApoL1 overexpression drives variant-independent cytotoxicity","volume":"29","author":"O'Toole","year":"2018","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/geno.2001.6534","article-title":"The human apolipoprotein L gene cluster: identification, classification, and sites of distribution","volume":"74","author":"Page","year":"2001","journal-title":"Genomics"},{"key":"2022012608060038000_DMM048952C55","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"P\u00e9rez-Morga","year":"2005","journal-title":"Science"},{"key":"2022012608060038000_DMM048952C56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000445171","article-title":"Non-transgenic mouse models of kidney disease","volume":"133","author":"Rabe","year":"2016","journal-title":"Nephron"},{"key":"2022012608060038000_DMM048952C57","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am. J. Transplant"},{"key":"2022012608060038000_DMM048952C58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cytogfr.2007.06.021","article-title":"STAT dynamics","volume":"18","author":"Reich","year":"2007","journal-title":"Cytokine Growth Factor. Rev."},{"key":"2022012608060038000_DMM048952C59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00467-006-0357-2","article-title":"Pathophysiology of focal segmental glomerulosclerosis","volume":"22","author":"Reidy","year":"2007","journal-title":"Pediatr. Nephrol"},{"key":"2022012608060038000_DMM048952C60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00498","article-title":"The significance of interferon-\u03b3 in HIV-1 pathogenesis, therapy, and prophylaxis","volume":"4","author":"Roff","year":"2013","journal-title":"Front. Immunol"},{"key":"2022012608060038000_DMM048952C61","doi-asserted-by":"publisher","first-page":"e0125410","DOI":"10.1371\/journal.pone.0125410","article-title":"Copy number variation at the APOL1 locus","volume":"10","author":"Ruchi","year":"2015","journal-title":"PLoS ONE"},{"key":"2022012608060038000_DMM048952C62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0211559","article-title":"APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice","volume":"14","author":"Ryu","year":"2019","journal-title":"PLoS ONE"},{"key":"2022012608060038000_DMM048952C63","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1681\/ASN.2019080829","article-title":"Apolipoprotein L1-specific antibodies detect endogenous apol1 inside the endoplasmic reticulum and on the plasma membrane of podocytes","volume":"31","author":"Scales","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C64","first-page":"1510","article-title":"Translating mouse models: immune variation and efficacy testing","volume":"77","author":"Sellers","year":"2017","journal-title":"Toxicol. Pathol"},{"key":"2022012608060038000_DMM048952C65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet. Pathol"},{"key":"2022012608060038000_DMM048952C66","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1681\/ASN.2019020114","article-title":"APOL1 kidney risk variants induce cell death via mitochondrial translocation and opening of the mitochondrial permeability transition pore","volume":"30","author":"Shah","year":"2019","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C67","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1111\/febs.13706","article-title":"Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1","volume":"283","author":"Sharma","year":"2016","journal-title":"FEBS J."},{"key":"2022012608060038000_DMM048952C68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.xkme.2020.05.005","article-title":"COVID-19\u2013associated collapsing focal segmental glomerulosclerosis: a report of 2 cases","volume":"2","author":"Sharma","year":"2020","journal-title":"Kidney Med"},{"key":"2022012608060038000_DMM048952C69","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1681\/ASN.2016040441","article-title":"Most ApoL1 is secreted by the liver","volume":"28","author":"Shukha","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"2022012608060038000_DMM048952C70","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith","year":"2009","journal-title":"Genome Res."},{"key":"2022012608060038000_DMM048952C71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.adgen.2014.10.002","article-title":"Hydrodynamic delivery","volume":"89","author":"Suda","year":"2015","journal-title":"Adv. Genet"},{"key":"2022012608060038000_DMM048952C72","doi-asserted-by":"publisher","first-page":"762419","DOI":"10.1155\/2015\/762419","article-title":"Effect of crossing C57BL\/6 and FVB mouse strains on basal cytokine expression","volume":"2015","author":"Szade","year":"2015","journal-title":"Mediators Inflamm."},{"key":"2022012608060038000_DMM048952C73","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","article-title":"A new method for large scale isolation of kidney glomeruli from mice","volume":"161","author":"Takemoto","year":"2002","journal-title":"Am. J. Pathol"},{"key":"2022012608060038000_DMM048952C74","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-015-1821-9","article-title":"Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis","volume":"467","author":"Taneda","year":"2015","journal-title":"Virchows Arch."},{"key":"2022012608060038000_DMM048952C75","doi-asserted-by":"publisher","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022012608060038000_DMM048952C76","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum. Genet"},{"key":"2022012608060038000_DMM048952C77","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"2022012608060038000_DMM048952C78","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1053\/j.ajkd.2019.06.006","article-title":"Genetics and ESKD Disparities in African Americans","volume":"74","author":"Umeukeje","year":"2019","journal-title":"Am. J. Kidney Dis"},{"key":"2022012608060038000_DMM048952C79","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.celrep.2020.02.064","article-title":"APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin","volume":"30","author":"Uzureau","year":"2020","journal-title":"Cell Rep"},{"key":"2022012608060038000_DMM048952C80","doi-asserted-by":"crossref","first-page":"e0198013","DOI":"10.1371\/journal.pone.0198013","article-title":"Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus","volume":"13","author":"Verma","year":"2018","journal-title":"PLoS ONE"},{"key":"2022012608060038000_DMM048952C81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12879-018-3643-2","article-title":"Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-\u03b3: a multicenter observational study","volume":"19","author":"Watanabe","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"2022012608060038000_DMM048952C82","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with covid-19 and apol1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022012608060038000_DMM048952C83","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semnephrol.2008.08.005","article-title":"HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy","volume":"28","author":"Wyatt","year":"2008","journal-title":"Semin. Nephrol"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.048952\/2127697\/dmm048952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.048952\/2127697\/dmm048952.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T08:06:12Z","timestamp":1643184372000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/14\/8\/dmm048952\/271190\/Recessive-gain-of-function-toxicity-in-an-APOL1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.048952","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]},"article-number":"dmm048952"}}